Edition:
United States

aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

3.10USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$3.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
27,230
52-wk High
$10.93
52-wk Low
$2.48

Select another date:

Mon, Nov 21 2016

BRIEF-Atyr Pharma enters into $20 million credit facility

* Intends to use additional capital to pay off existing indebtedness

BRIEF-Atyr Pharma reports Q3 loss per share of $0.58

* Qtrly net loss per share attributable to common stockholders $0.58

BRIEF-Atyr Pharma receives FDA fast track designation for Resolaris to treat FSHD

* Atyr Pharma receives FDA fast track designation for Resolaris to treat facioscapulohumeral muscular dystrophy (FSHD)

BRIEF-Atyr Pharma Inc qtrly loss per share $0.65

* Atyr Pharma announces second quarter 2016 operating results

Select another date: